Edition:
United Kingdom

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

3.52USD
23 Feb 2018
Change (% chg)

$0.11 (+3.23%)
Prev Close
$3.41
Open
$3.45
Day's High
$3.54
Day's Low
$3.42
Volume
607
Avg. Vol
5,709
52-wk High
$4.66
52-wk Low
$2.31

Chart for

About

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients... (more)
No analyst recommendations are available for .

Overall

Beta: -0.44
Market Cap(Mil.): $38.23
Shares Outstanding(Mil.): 10.99
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Champions Oncology Reports Record Quarterly Revenue Of $5.2 Million

* CHAMPIONS ONCOLOGY REPORTS RECORD QUARTERLY REVENUE OF $5.2 MILLION

07 Dec 2017

BRIEF-Champions Biotechnology reports Q1 loss per share $0.06

* Champions Oncology reports record quarterly revenue of $5 million

14 Sep 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $132.02 +2.11
Abbott Laboratories (ABT.N) $59.71 +0.72
Bayer AG (BAYGn.DE) €97.92 -0.52
Bayer AG (BAYE.F) -- --
GlaxoSmithKline plc (GSK.L) 1,296.00 -7.00
Biocon Ltd (BION.NS) Rs628.25 +8.50

Earnings vs. Estimates

No consensus analysis data available.